Startup Clairity scored a greenlight from the FDA for the agency's first artificial intelligence tool designed to predict ...

Rising temperatures are linked to increases in the prevalence and mortality of breast, ovarian, uterine, and cervical cancers ...

A breakthrough in AI breast cancer detection technology has been approved by the FDA. The tech company, “Clarity,” is responsible for the first FDA-approved AI platform that helps predict a woman’s ...

Researchers from the Hong Kong University of Science and Technology (HKUST) have developed Mixture of Modality Experts (MOME) ...

The global market for digital breast tomosynthesis (DBT) equipment is forecasted to attain USD 3,267.6 million by 2025, ...

NEW YORK, DE, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The global digital breast tomosynthesis (DBT) equipment market is estimated to be valued at USD 3.26 billion in 2025 and is projected to ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5% ...

LeConte Medical Center in Sevierville hopes to bring services closer to those who need prevention and treatment in Sevier County.

As a radiologist specializing in breast cancer imaging, I have unfortunately diagnosed many Wisconsin women with late-stage ...